192 related articles for article (PubMed ID: 31726453)
1. Association between Biomarkers of Mineral and Bone Metabolism and Removal of Calcium and Phosphate in Hemodialysis.
Debowska M; Dai L; Wojcik-Zaluska A; Poleszczuk J; Zaluska W; Lindholm B; Waniewski J
Blood Purif; 2020; 49(1-2):71-78. PubMed ID: 31726453
[TBL] [Abstract][Full Text] [Related]
2. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
Weinreich T; Ritz E; Passlick-Deetjen J
Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
[TBL] [Abstract][Full Text] [Related]
3. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
[TBL] [Abstract][Full Text] [Related]
4. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
[TBL] [Abstract][Full Text] [Related]
5. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
Rudnicki M; Frølich A; Haaber A; Tvedegaard E; Thode J
Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
Brandi L; Daugaard H; Nielsen PK; Jensen LT; Egsmose C; Olgaard K
Nephron; 1996; 74(1):89-103. PubMed ID: 8883025
[TBL] [Abstract][Full Text] [Related]
7. Phosphate Kinetics During Weekly Cycle of Hemodialysis Sessions: Application of Mathematical Modeling.
Debowska M; Poleszczuk J; Wojcik-Zaluska A; Ksiazek A; Zaluska W
Artif Organs; 2015 Dec; 39(12):1005-14. PubMed ID: 25994493
[TBL] [Abstract][Full Text] [Related]
8. Secretion of parathyroid hormone oscillates depending on the change in serum ionized calcium during hemodialysis and may affect bone metabolism.
Kitahara T; Ueki K; Kuroiwa T; Kaneko Y; Hiromura K; Nojima Y
Nephron Clin Pract; 2005; 101(1):c9-17. PubMed ID: 15886497
[TBL] [Abstract][Full Text] [Related]
9. Variability in measures of mineral metabolism in children on hemodialysis: impact on clinical decision-making.
Kakajiwala A; Jemielita TO; Copelovitch L; Leonard MB; Furth SL; York A; Benton M; Hoofnagle AN; Windt K; Merrigan K; Lederman A; Denburg MR
Pediatr Nephrol; 2017 Dec; 32(12):2311-2318. PubMed ID: 28667458
[TBL] [Abstract][Full Text] [Related]
10. Association between phosphate removal and markers of bone turnover in haemodialysis patients.
Albalate M; de la Piedra C; Fernández C; Lefort M; Santana H; Hernando P; Hernández J; Caramelo C
Nephrol Dial Transplant; 2006 Jun; 21(6):1626-32. PubMed ID: 16490746
[TBL] [Abstract][Full Text] [Related]
11. [Acute response of serum PTH and bone markers after injection of 1alpha,25 (OH)2D3 and 22-oxacalcitrol in hemodialysis patient].
Shimizu G; Mitani S; Matsumoto S; Kawakami A; Nozaki K; Naka H; Imanishi Y; Miki T; Inaba M; Nishizawa Y
Clin Calcium; 2005 Sep; 15 Suppl 1():148-51; discussion 151. PubMed ID: 16272648
[TBL] [Abstract][Full Text] [Related]
12. Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study.
Tagawa M; Hamano T; Nishi H; Tsuchida K; Hanafusa N; Fukatsu A; Iseki K; Tsubakihara Y
PLoS One; 2014; 9(12):e114678. PubMed ID: 25494334
[TBL] [Abstract][Full Text] [Related]
13. Effects of lanthanum carbonate on bone markers and bone mineral density in incident hemodialysis patients.
Goto K; Goto S; Fujii H; Watanabe K; Kono K; Nishi S
J Bone Miner Metab; 2019 Nov; 37(6):1075-1082. PubMed ID: 31214836
[TBL] [Abstract][Full Text] [Related]
14. Comparison of calcium carbonate and aluminium hydroxide as phosphate binders on biochemical bone markers, PTH(1-84), and bone mineral content in dialysis patients.
Jespersen B; Jensen JD; Nielsen HK; Lauridsen IN; Andersen MJ; Poulsen JH; Gammelgaard B; Pedersen EB
Nephrol Dial Transplant; 1991; 6(2):98-104. PubMed ID: 1857534
[TBL] [Abstract][Full Text] [Related]
15. Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover.
Shigematsu T; Kawaguchi Y; Kubo H; Nakayama M; Kato N; Yamamoto H; Osaka N; Hayakawa H; Ogawa A; Sakai O
Adv Perit Dial; 1996; 12():250-6. PubMed ID: 8865914
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis.
Gardham C; Stevens PE; Delaney MP; LeRoux M; Coleman A; Lamb EJ
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1261-7. PubMed ID: 20498246
[TBL] [Abstract][Full Text] [Related]
18. The influence of smoking on vitamin D status and calcium metabolism.
Brot C; Jorgensen NR; Sorensen OH
Eur J Clin Nutr; 1999 Dec; 53(12):920-6. PubMed ID: 10602348
[TBL] [Abstract][Full Text] [Related]
19. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
20. Effect of vitamin D receptor activator therapy on vitamin D receptor and osteocalcin expression in circulating endothelial progenitor cells of hemodialysis patients.
Cianciolo G; La Manna G; Della Bella E; Cappuccilli ML; Angelini ML; Dormi A; Capelli I; Laterza C; Costa R; Alviano F; Donati G; Ronco C; Stefoni S
Blood Purif; 2013; 35(1-3):187-95. PubMed ID: 23485859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
